Does the media prefer MLAB or ALMR?

In the previous week, Mesa Laboratories had 1 more articles in the media than Alamar Biosciences. MarketBeat recorded 3 mentions for Mesa Laboratories and 2 mentions for Alamar Biosciences. Mesa Laboratories' average media sentiment score of 0.54 beat Alamar Biosciences' score of 0.00 indicating that Mesa Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mesa Laboratories 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alamar Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to MRVI or MLAB?

In the previous week, Maravai LifeSciences had 2 more articles in the media than Mesa Laboratories. MarketBeat recorded 5 mentions for Maravai LifeSciences and 3 mentions for Mesa Laboratories. Maravai LifeSciences' average media sentiment score of 0.66 beat Mesa Laboratories' score of 0.54 indicating that Maravai LifeSciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Maravai LifeSciences 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Mesa Laboratories 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer MLAB or PSNL?

In the previous week, Personalis had 2 more articles in the media than Mesa Laboratories. MarketBeat recorded 5 mentions for Personalis and 3 mentions for Mesa Laboratories. Personalis' average media sentiment score of 0.93 beat Mesa Laboratories' score of 0.54 indicating that Personalis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mesa Laboratories 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Personalis 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to BLFS or MLAB?

In the previous week, Mesa Laboratories had 2 more articles in the media than BioLife Solutions. MarketBeat recorded 3 mentions for Mesa Laboratories and 1 mentions for BioLife Solutions. Mesa Laboratories' average media sentiment score of 0.54 beat BioLife Solutions' score of 0.00 indicating that Mesa Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Mesa Laboratories 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MLAB or FTRE?

In the previous week, Fortrea had 6 more articles in the media than Mesa Laboratories. MarketBeat recorded 9 mentions for Fortrea and 3 mentions for Mesa Laboratories. Mesa Laboratories' average media sentiment score of 0.54 beat Fortrea's score of 0.37 indicating that Mesa Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mesa Laboratories 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fortrea 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Mesa Laboratories (MLAB) Competitors

$128.53 -2.12 (-1.62%)

As of 04:00 PM Eastern

Compare

MLAB vs. ALMR, MRVI, PSNL, BLFS, and FTRE

Should you buy Mesa Laboratories stock or one of its competitors? Mesa Laboratories's main competitors and comparable companies include Alamar Biosciences (ALMR), Maravai LifeSciences (MRVI), Personalis (PSNL), BioLife Solutions (BLFS), and Fortrea (FTRE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Mesa Laboratories compare to Alamar Biosciences?

Mesa Laboratories (NASDAQ:MLAB) and Alamar Biosciences (NASDAQ:ALMR) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations.

Mesa Laboratories has higher revenue and earnings than Alamar Biosciences. Alamar Biosciences is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mesa Laboratories	$249.13M	2.89	$6.71M	$0.84	153.01
Alamar Biosciences	$74.21M	28.58	-$29.82M	-$1.96	N/A

Mesa Laboratories has a net margin of 1.92% compared to Alamar Biosciences' net margin of 0.00%. Mesa Laboratories' return on equity of 22.72% beat Alamar Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mesa Laboratories	1.92%	22.72%	9.82%
Alamar Biosciences	N/A	N/A	N/A

90.6% of Mesa Laboratories shares are held by institutional investors. 2.8% of Mesa Laboratories shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Mesa Laboratories currently has a consensus price target of $110.00, suggesting a potential downside of 14.42%. Alamar Biosciences has a consensus price target of $31.80, suggesting a potential upside of 4.02%. Given Alamar Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe Alamar Biosciences is more favorable than Mesa Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mesa Laboratories	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Alamar Biosciences	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

In the previous week, Mesa Laboratories had 1 more articles in the media than Alamar Biosciences. MarketBeat recorded 3 mentions for Mesa Laboratories and 2 mentions for Alamar Biosciences. Mesa Laboratories' average media sentiment score of 0.54 beat Alamar Biosciences' score of 0.00 indicating that Mesa Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mesa Laboratories	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alamar Biosciences	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Mesa Laboratories beats Alamar Biosciences on 11 of the 15 factors compared between the two stocks.

How does Mesa Laboratories compare to Maravai LifeSciences?

Maravai LifeSciences (NASDAQ:MRVI) and Mesa Laboratories (NASDAQ:MLAB) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.

Maravai LifeSciences currently has a consensus price target of $6.25, indicating a potential downside of 15.20%. Mesa Laboratories has a consensus price target of $110.00, indicating a potential downside of 14.42%. Given Mesa Laboratories' higher possible upside, analysts plainly believe Mesa Laboratories is more favorable than Maravai LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Maravai LifeSciences	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
Mesa Laboratories	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

50.3% of Maravai LifeSciences shares are held by institutional investors. Comparatively, 90.6% of Mesa Laboratories shares are held by institutional investors. 2.5% of Maravai LifeSciences shares are held by company insiders. Comparatively, 2.8% of Mesa Laboratories shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Maravai LifeSciences has a beta of 0.6, meaning that its share price is 40% less volatile than the broader market. Comparatively, Mesa Laboratories has a beta of 0.97, meaning that its share price is 3% less volatile than the broader market.

In the previous week, Maravai LifeSciences had 2 more articles in the media than Mesa Laboratories. MarketBeat recorded 5 mentions for Maravai LifeSciences and 3 mentions for Mesa Laboratories. Maravai LifeSciences' average media sentiment score of 0.66 beat Mesa Laboratories' score of 0.54 indicating that Maravai LifeSciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Maravai LifeSciences	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Mesa Laboratories	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Mesa Laboratories has higher revenue and earnings than Maravai LifeSciences. Maravai LifeSciences is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Maravai LifeSciences	$185.74M	10.30	-$130.77M	-$0.52	N/A
Mesa Laboratories	$249.13M	2.89	$6.71M	$0.84	153.01

Mesa Laboratories has a net margin of 1.92% compared to Maravai LifeSciences' net margin of -37.07%. Mesa Laboratories' return on equity of 22.72% beat Maravai LifeSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Maravai LifeSciences	-37.07%	-15.70%	-8.17%
Mesa Laboratories	1.92%	22.72%	9.82%

Summary

Mesa Laboratories beats Maravai LifeSciences on 11 of the 15 factors compared between the two stocks.

How does Mesa Laboratories compare to Personalis?

Mesa Laboratories (NASDAQ:MLAB) and Personalis (NASDAQ:PSNL) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and dividends.

Mesa Laboratories currently has a consensus price target of $110.00, suggesting a potential downside of 14.42%. Personalis has a consensus price target of $14.54, suggesting a potential downside of 13.63%. Given Personalis' stronger consensus rating and higher possible upside, analysts clearly believe Personalis is more favorable than Mesa Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mesa Laboratories	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Personalis	2 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.20

90.6% of Mesa Laboratories shares are held by institutional investors. Comparatively, 61.9% of Personalis shares are held by institutional investors. 2.8% of Mesa Laboratories shares are held by insiders. Comparatively, 4.2% of Personalis shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Mesa Laboratories has a net margin of 1.92% compared to Personalis' net margin of -153.84%. Mesa Laboratories' return on equity of 22.72% beat Personalis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mesa Laboratories	1.92%	22.72%	9.82%
Personalis	-153.84%	-46.47%	-35.30%

Mesa Laboratories has a beta of 0.97, meaning that its share price is 3% less volatile than the broader market. Comparatively, Personalis has a beta of 2.31, meaning that its share price is 131% more volatile than the broader market.

In the previous week, Personalis had 2 more articles in the media than Mesa Laboratories. MarketBeat recorded 5 mentions for Personalis and 3 mentions for Mesa Laboratories. Personalis' average media sentiment score of 0.93 beat Mesa Laboratories' score of 0.54 indicating that Personalis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mesa Laboratories	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Personalis	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Mesa Laboratories has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mesa Laboratories	$249.13M	2.89	$6.71M	$0.84	153.01
Personalis	$69.65M	25.30	-$81.27M	-$1.09	N/A

Summary

Mesa Laboratories and Personalis tied by winning 8 of the 16 factors compared between the two stocks.

How does Mesa Laboratories compare to BioLife Solutions?

BioLife Solutions (NASDAQ:BLFS) and Mesa Laboratories (NASDAQ:MLAB) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations.

93.2% of BioLife Solutions shares are owned by institutional investors. Comparatively, 90.6% of Mesa Laboratories shares are owned by institutional investors. 2.2% of BioLife Solutions shares are owned by company insiders. Comparatively, 2.8% of Mesa Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

BioLife Solutions currently has a consensus price target of $31.38, suggesting a potential downside of 11.69%. Mesa Laboratories has a consensus price target of $110.00, suggesting a potential downside of 14.42%. Given BioLife Solutions' stronger consensus rating and higher probable upside, equities analysts clearly believe BioLife Solutions is more favorable than Mesa Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLife Solutions	1 Sell rating(s)	8 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.18
Mesa Laboratories	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Mesa Laboratories has higher revenue and earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLife Solutions	$106.69M	16.27	-$4.59M	$1.16	30.63
Mesa Laboratories	$249.13M	2.89	$6.71M	$0.84	153.01

BioLife Solutions has a beta of 1.91, indicating that its stock price is 91% more volatile than the broader market. Comparatively, Mesa Laboratories has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market.

BioLife Solutions has a net margin of 53.29% compared to Mesa Laboratories' net margin of 1.92%. Mesa Laboratories' return on equity of 22.72% beat BioLife Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioLife Solutions	53.29%	2.70%	2.49%
Mesa Laboratories	1.92%	22.72%	9.82%

In the previous week, Mesa Laboratories had 2 more articles in the media than BioLife Solutions. MarketBeat recorded 3 mentions for Mesa Laboratories and 1 mentions for BioLife Solutions. Mesa Laboratories' average media sentiment score of 0.54 beat BioLife Solutions' score of 0.00 indicating that Mesa Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BioLife Solutions	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Mesa Laboratories	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

BioLife Solutions beats Mesa Laboratories on 9 of the 17 factors compared between the two stocks.

How does Mesa Laboratories compare to Fortrea?

Mesa Laboratories (NASDAQ:MLAB) and Fortrea (NASDAQ:FTRE) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

In the previous week, Fortrea had 6 more articles in the media than Mesa Laboratories. MarketBeat recorded 9 mentions for Fortrea and 3 mentions for Mesa Laboratories. Mesa Laboratories' average media sentiment score of 0.54 beat Fortrea's score of 0.37 indicating that Mesa Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mesa Laboratories	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fortrea	2 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Mesa Laboratories has a beta of 0.97, indicating that its share price is 3% less volatile than the broader market. Comparatively, Fortrea has a beta of 1.97, indicating that its share price is 97% more volatile than the broader market.

90.6% of Mesa Laboratories shares are owned by institutional investors. 2.8% of Mesa Laboratories shares are owned by insiders. Comparatively, 0.7% of Fortrea shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Mesa Laboratories presently has a consensus price target of $110.00, suggesting a potential downside of 14.42%. Fortrea has a consensus price target of $20.75, suggesting a potential upside of 11.44%. Given Fortrea's stronger consensus rating and higher possible upside, analysts clearly believe Fortrea is more favorable than Mesa Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mesa Laboratories	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Fortrea	1 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.33

Mesa Laboratories has a net margin of 1.92% compared to Fortrea's net margin of -3.18%. Mesa Laboratories' return on equity of 22.72% beat Fortrea's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mesa Laboratories	1.92%	22.72%	9.82%
Fortrea	-3.18%	10.72%	2.17%

Mesa Laboratories has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mesa Laboratories	$249.13M	2.89	$6.71M	$0.84	153.01
Fortrea	$2.72B	0.65	-$986.20M	-$0.91	N/A

Summary

Mesa Laboratories beats Fortrea on 10 of the 16 factors compared between the two stocks.

Get Mesa Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MLAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MLAB vs. The Competition

Export

Metric	Mesa Laboratories	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$719.77M	$10.02B	$7.24B	$12.90B
Dividend Yield	0.51%	1.47%	2.53%	8.56%
P/E Ratio	153.01	64.84	273.57	25.42
Price / Sales	2.89	112.60	675.05	123.41
Price / Cash	10.66	26.42	76.98	52.08
Price / Book	3.81	36.39	12.91	6.15
Net Income	$6.71M	$56.67B	$3.47B	$349.01M
7 Day Performance	-0.09%	-2.72%	-0.46%	-1.48%
1 Month Performance	23.08%	5.39%	6.40%	2.46%
1 Year Performance	109.37%	26.77%	24.88%	15.76%

Mesa Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MLAB Mesa Laboratories	1.2404 of 5 stars	$128.53 -1.6%	$110.00 -14.4%	+103.5%	$719.77M	$249.13M	153.01	680	Ex-Dividend
ALMR Alamar Biosciences	1.6242 of 5 stars	$29.36 -3.9%	$31.80 +8.3%	N/A	$2.04B	$74.21M	N/A	222
MRVI Maravai LifeSciences	1.233 of 5 stars	$7.30 -4.5%	$6.25 -14.4%	+211.4%	$1.90B	$185.74M	N/A	610
PSNL Personalis	1.7537 of 5 stars	$17.06 +1.7%	$14.54 -14.8%	+247.8%	$1.79B	$69.65M	N/A	400	News Coverage
BLFS BioLife Solutions	2.6103 of 5 stars	$35.47 -4.3%	$31.38 -11.5%	+41.8%	$1.73B	$96.21M	30.58	440	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MLAB) was last updated on 9/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mesa Laboratories (MLAB) Competitors

MLAB vs. ALMR, MRVI, PSNL, BLFS, and FTRE

How does Mesa Laboratories compare to Alamar Biosciences?

Summary

How does Mesa Laboratories compare to Maravai LifeSciences?

Summary

How does Mesa Laboratories compare to Personalis?

Summary

How does Mesa Laboratories compare to BioLife Solutions?

Summary

How does Mesa Laboratories compare to Fortrea?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLAB vs. The Competition

Mesa Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Mesa Laboratories (MLAB) Competitors

MLAB vs. ALMR, MRVI, PSNL, BLFS, and FTRE

How does Mesa Laboratories compare to Alamar Biosciences?

Which has better earnings and valuation, MLAB or ALMR?

Is MLAB or ALMR more profitable?

Do institutionals & insiders have more ownership in MLAB or ALMR?

Do analysts rate MLAB or ALMR?

Does the media prefer MLAB or ALMR?

Summary

How does Mesa Laboratories compare to Maravai LifeSciences?

Do analysts rate MRVI or MLAB?

Do institutionals and insiders believe in MRVI or MLAB?

Which has more volatility and risk, MRVI or MLAB?

Does the media refer more to MRVI or MLAB?

Which has stronger valuation and earnings, MRVI or MLAB?

Is MRVI or MLAB more profitable?

Summary

How does Mesa Laboratories compare to Personalis?

Do analysts rate MLAB or PSNL?

Do insiders & institutionals hold more shares of MLAB or PSNL?

Is MLAB or PSNL more profitable?

Which has more risk and volatility, MLAB or PSNL?

Does the media prefer MLAB or PSNL?

Which has preferable earnings & valuation, MLAB or PSNL?

Summary

How does Mesa Laboratories compare to BioLife Solutions?

Do insiders and institutionals hold more shares of BLFS or MLAB?

Do analysts prefer BLFS or MLAB?

Which has preferable earnings and valuation, BLFS or MLAB?

Which has more risk and volatility, BLFS or MLAB?

Is BLFS or MLAB more profitable?

Does the media refer more to BLFS or MLAB?

Summary

How does Mesa Laboratories compare to Fortrea?

Does the media favor MLAB or FTRE?

Which has more volatility and risk, MLAB or FTRE?

Do insiders and institutionals have more ownership in MLAB or FTRE?

Do analysts recommend MLAB or FTRE?

Is MLAB or FTRE more profitable?

Which has preferable earnings and valuation, MLAB or FTRE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLAB vs. The Competition

Mesa Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools